{"title":"孟加拉国年轻成年女性风疹血清阳性及相关因素:一项横断面研究。","authors":"Md Nuruzzaman, Wit Wichaidit, Quazi Monirul Islam, Afzalun Nessa, Tippawan Liabsuetrakul","doi":"10.2147/IJGM.S536793","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>A cross-sectional study was conducted among young female adults aged 18 to 24 years in Bangladesh to assess rubella IgG seropositivity and associated factors.</p><p><strong>Methods: </strong>Data were collected on participants' sociodemographic and family characteristics, residency and age during 2014 Measles-Rubella campaign, and rubella vaccination history. Blood samples were collected and tested for rubella virus-specific immunoglobulin G (IgG) antibodies (rubella IgG) using chemiluminescence immunoassay.</p><p><strong>Results: </strong>Of the 250 young female adults aged 18-24 years, 87.20% (95% CI: 83.06%-91.34%) were seropositive for rubella IgG: 89.47% among the vaccinated, 85.93% among the non-vaccinated, and 88.54% among those with unknown vaccination history. Seropositivity was not significantly associated with reported rubella vaccination history. Titer levels were significantly higher in seropositive participants without a vaccination history (Median 66.75 IU/mL; interquartile range (IQR): 42.53-98.47) than those with a history (Median 37.30 IU/mL; IQR: 29.70-65.60). Compared with those from rural locations, participants from urban locations had significantly lower odds of seropositivity (Odds Ratio 0.33; 95% CI: 0.12-0.92; p = 0.035).</p><p><strong>Conclusion: </strong>A relatively high prevalence of rubella IgG seropositivity was detected. However, approximately one in ten participants remained susceptible to rubella infection during pregnancy and at risk of related adverse outcomes, including congenital rubella syndrome. Seropositivity was not associated with rubella vaccination history suggesting endemic transmission of the rubella virus. The low proportion of participants with a known vaccination history indicates gaps in vaccination documentation. Therefore, well-recorded vaccination histories and strengthened surveillance systems should be developed.</p>","PeriodicalId":14131,"journal":{"name":"International Journal of General Medicine","volume":"18 ","pages":"6043-6054"},"PeriodicalIF":2.0000,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12502957/pdf/","citationCount":"0","resultStr":"{\"title\":\"Rubella Seropositivity and Associated Factors Among Young Female Adults in Bangladesh: A Cross-Sectional Study.\",\"authors\":\"Md Nuruzzaman, Wit Wichaidit, Quazi Monirul Islam, Afzalun Nessa, Tippawan Liabsuetrakul\",\"doi\":\"10.2147/IJGM.S536793\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>A cross-sectional study was conducted among young female adults aged 18 to 24 years in Bangladesh to assess rubella IgG seropositivity and associated factors.</p><p><strong>Methods: </strong>Data were collected on participants' sociodemographic and family characteristics, residency and age during 2014 Measles-Rubella campaign, and rubella vaccination history. Blood samples were collected and tested for rubella virus-specific immunoglobulin G (IgG) antibodies (rubella IgG) using chemiluminescence immunoassay.</p><p><strong>Results: </strong>Of the 250 young female adults aged 18-24 years, 87.20% (95% CI: 83.06%-91.34%) were seropositive for rubella IgG: 89.47% among the vaccinated, 85.93% among the non-vaccinated, and 88.54% among those with unknown vaccination history. Seropositivity was not significantly associated with reported rubella vaccination history. Titer levels were significantly higher in seropositive participants without a vaccination history (Median 66.75 IU/mL; interquartile range (IQR): 42.53-98.47) than those with a history (Median 37.30 IU/mL; IQR: 29.70-65.60). Compared with those from rural locations, participants from urban locations had significantly lower odds of seropositivity (Odds Ratio 0.33; 95% CI: 0.12-0.92; p = 0.035).</p><p><strong>Conclusion: </strong>A relatively high prevalence of rubella IgG seropositivity was detected. However, approximately one in ten participants remained susceptible to rubella infection during pregnancy and at risk of related adverse outcomes, including congenital rubella syndrome. Seropositivity was not associated with rubella vaccination history suggesting endemic transmission of the rubella virus. The low proportion of participants with a known vaccination history indicates gaps in vaccination documentation. Therefore, well-recorded vaccination histories and strengthened surveillance systems should be developed.</p>\",\"PeriodicalId\":14131,\"journal\":{\"name\":\"International Journal of General Medicine\",\"volume\":\"18 \",\"pages\":\"6043-6054\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2025-10-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12502957/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of General Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/IJGM.S536793\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of General Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IJGM.S536793","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
Rubella Seropositivity and Associated Factors Among Young Female Adults in Bangladesh: A Cross-Sectional Study.
Purpose: A cross-sectional study was conducted among young female adults aged 18 to 24 years in Bangladesh to assess rubella IgG seropositivity and associated factors.
Methods: Data were collected on participants' sociodemographic and family characteristics, residency and age during 2014 Measles-Rubella campaign, and rubella vaccination history. Blood samples were collected and tested for rubella virus-specific immunoglobulin G (IgG) antibodies (rubella IgG) using chemiluminescence immunoassay.
Results: Of the 250 young female adults aged 18-24 years, 87.20% (95% CI: 83.06%-91.34%) were seropositive for rubella IgG: 89.47% among the vaccinated, 85.93% among the non-vaccinated, and 88.54% among those with unknown vaccination history. Seropositivity was not significantly associated with reported rubella vaccination history. Titer levels were significantly higher in seropositive participants without a vaccination history (Median 66.75 IU/mL; interquartile range (IQR): 42.53-98.47) than those with a history (Median 37.30 IU/mL; IQR: 29.70-65.60). Compared with those from rural locations, participants from urban locations had significantly lower odds of seropositivity (Odds Ratio 0.33; 95% CI: 0.12-0.92; p = 0.035).
Conclusion: A relatively high prevalence of rubella IgG seropositivity was detected. However, approximately one in ten participants remained susceptible to rubella infection during pregnancy and at risk of related adverse outcomes, including congenital rubella syndrome. Seropositivity was not associated with rubella vaccination history suggesting endemic transmission of the rubella virus. The low proportion of participants with a known vaccination history indicates gaps in vaccination documentation. Therefore, well-recorded vaccination histories and strengthened surveillance systems should be developed.
期刊介绍:
The International Journal of General Medicine is an international, peer-reviewed, open access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treatment protocols. The journal is characterized by the rapid reporting of reviews, original research and clinical studies across all disease areas.
A key focus of the journal is the elucidation of disease processes and management protocols resulting in improved outcomes for the patient. Patient perspectives such as satisfaction, quality of life, health literacy and communication and their role in developing new healthcare programs and optimizing clinical outcomes are major areas of interest for the journal.
As of 1st April 2019, the International Journal of General Medicine will no longer consider meta-analyses for publication.